(STEP-1 Trial, NEJM 2021) The STEP 5 two-year trial found no new risks emerging over time
For those exploring alternatives, our guides on Ozempic alternatives and the best weight loss peptides provide comprehensive comparisons
There have been some impressive transformations reported in clinical trials, including significant reductions in body weight and improvements in metabolic markers as a result of the intervention
Recent Updates: November 24, 2025: Updated Zepbound Self-Pay pricing and added 45-day refill requirement for discounted doses
Therefore, in this study we characterized the signaling profiles of endogenous agonists GIP(1-42) and GIP(1-30)NH 2 and the drug tirzepatide at two GIP receptor isoforms, wildtype and E354Q, for five signaling pathways potentially relevant to the physiological actions of GIP in metabolism
Why consider switching from semaglutide to tirzepatide